Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Plos Computational Biology|March 18, 2021
Boosting GWAS using biological networks: A study on susceptibility to familial breast cancerHéctor Climente-González, Christine Lonjou, Fabienne Lesueur, et al.Proceedings of the National Academy of Sciences of the United States of America|May 2, 2003
Linkage disequilibrium in human populationsChristine Lonjou, Weihua Zhang, Andrew Collins, et al.AIDS (London, England)|February 28, 2008
HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenzZulma G Vitezica, Brigitte Milpied, Christine Lonjou, et al.BMC Cancer|May 14, 2017
Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiationChristine Lonjou, Francesca Damiola, Monika Moissonnier, et al.Molecular Vision|July 9, 2011
A novel DFNB31 mutation associated with Usher type 2 syndrome showing variable degrees of auditory loss in a consanguineous Portuguese familyIsabelle Audo, Kinga Bujakowska, Saddek Mohand-Saïd, et al.Nature Genetics|December 3, 2013
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertensionMélanie Eyries, David Montani, Barbara Girerd, et al.European Journal of Human Genetics : EJHG|January 24, 2013
Positive selection of protective variants for type 2 diabetes from the Neolithic onward: a case study in Central AsiaLaure Ségurel, Frederic Austerlitz, Bruno Toupance, et al.Pharmacogenetics and Genomics|January 15, 2008
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugsChristine Lonjou, Nicolas Borot, Peggy Sekula, et al.Human Mutation|November 9, 2011
CRB1 mutations in inherited retinal dystrophiesKinga Bujakowska, Isabelle Audo, Saddek Mohand-Saïd, et al.Nature Communications|January 12, 2025
Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancerNicolas Captier, Marvin Lerousseau, Fanny Orlhac, et al.Pageof 2